HAT inhibition resulted in the significantly reduced acetylation of histone H3 levels in the IL-6 promoter, as well as decreased IL-6 mRNA expression and IL-6 protein release by rheumatoid arthritis synovial fibroblasts [100]. This evidence concerns the gene IL6 and rheumatoid arthritis.